SOMANTA PHARMACEUTICALS
Somanta Pharmaceuticals a development stage biopharmaceutical company, develops drugs primarily for the treatment of cancer. It holds a license to develop Sodium Phenylbutyrate for the treatment of cancer, autoimmune diseases, and other clinical indications. The company's products in the pre-clinical stage of development include Alchemix, which is intended to interrupt various phases of the cancer cell growth cycle by selectively binding to DNA and inhibiting DNA processing enzymes to overcome drug resistant tumors.
SOMANTA PHARMACEUTICALS
Industry:
Biotechnology
Founded:
2001-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.somanta.com
Total Employee:
1+
Status:
Active
Contact:
949-477-8090
Total Funding:
4.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache AdBlock Acceptable Ads Register.com DNS Confluence Networks
Similar Organizations
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
Investors List
Xmark Asset Management
Xmark Asset Management investment in Venture Round - Somanta Pharmaceuticals
Alpha Capital
Alpha Capital investment in Venture Round - Somanta Pharmaceuticals
BF Holdings
BF Holdings investment in Venture Round - Somanta Pharmaceuticals
Whalehaven Capital Fund
Whalehaven Capital Fund investment in Venture Round - Somanta Pharmaceuticals
Official Site Inspections
http://www.somanta.com
- Host name: 204.11.56.43
- IP address: 204.11.56.43
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola
